Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes
AssigneeBayer Intellectual Property GmbH
InventorsJohannes-Peter Stasch, Eva-Maria Becker, Hubert Trübel, Herbert Himmel
Life of this patent
Estimating the term…
Abstract
The present invention relates to the novel use of stimulators and activators of soluble guanylate cyclase for the treatment of sickle cell anemia and for the preservation of blood substitutes. The present invention furthermore relates to the use of stimulators and activators of soluble guanylate cyclase in combination with PDE5 inhibitors for the treatment of sickle cell anemia and for the preservation of blood substitutes.
Claims15
A method of treatment of sickle cell anemia or for the preservation of blood substitutes, comprising administering a stimulator and/or activator of soluble guanylate cyclase to a human or animal in need thereof.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.